Label Changes for:

Eraxis (anidulafungin) Powder for Injection

July 2012

Changes have been made to the WARNINGS and PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) 

 

July 2012

WARNINGS AND PRECAUTIONS

Hypersensitivity
  • bronchospasm 

 

 

November 2010 

ADVERSE REACTIONS

  • General: bronchospasm
Hide
(web1)